Morpheus8 vs Vivace: Which RF Microneedling Device Delivers Better Skin Results?

morpheus8 vs vivace

Radiofrequency microneedling has become one of the most sought-after skin-tightening treatments in medspas, and Morpheus8 and Vivace are two of the most frequently compared devices in this category. Both combine microneedle penetration with radiofrequency energy delivery to remodel collagen at depth — but the devices differ meaningfully in needle depth, energy type, patient experience, and the clinical outcomes they are best suited to produce.

I work with medspa owners evaluating device investments, and the Morpheus8 versus Vivace question is one of the most nuanced in the space. Here is how I break down the clinical and business case for each.

Side-by-Side Specification Table

Understanding the Technology Difference

Both devices create micro-injuries through needles and deliver RF energy to heat dermal tissue, triggering collagen remodeling and neo-collagenesis. The key distinction is depth and energy magnitude.

Morpheus8, manufactured by InMode, can penetrate to 8 mm on the face — deep enough to reach the superficial fat compartments (SMAS layer) and subdermal tissue. At this depth, it is not just remodeling the dermis; it is remodeling the structural architecture of the face. This is what gives Morpheus8 the ability to address significant skin laxity and produce facial lifting effects that standard microneedling or surface-level RF cannot. The Morpheus8 Body tip extends needle depth to 24 mm for body applications.

Vivace, manufactured by Aesthetics Biomedical, delivers RF energy to a maximum of 3.5 mm — solidly within the dermis but not reaching the subcutaneous fat layer. This shallower depth produces meaningful collagen stimulation and skin texture improvement with significantly less trauma and downtime. The addition of LED light therapy (red for collagen stimulation, blue for bacterial reduction) adds a skin-quality benefit that Morpheus8 does not include as a built-in feature.

Pros and Cons: Morpheus8

Pros

• Deepest penetration of any mainstream RF microneedling device — addresses structural laxity that surface treatments cannot reach.
• Can treat subdermal fat deposits, making it useful for jawline definition, jowl reduction, and neck laxity in a way no other non-surgical device can match.
• Fewer sessions needed — most patients achieve significant results in 1–3 treatments.
• Strong celebrity and media recognition drives inbound patient interest without as much education required.
• Body applicator expands the treatment menu to include abdomen, arms, and thighs.

Cons

• Downtime of 3–7 days limits appeal for patients who cannot schedule recovery time.
• Higher pain level during treatment — some patients require local nerve blocks for comfort at maximum depths.
• Significantly higher per-session cost than Vivace — patient acquisition requires patients who can commit to the investment.
• Pinpoint bleeding and crusting is normal post-treatment — some patients find this alarming without adequate preparation.
• Risk of hyperpigmentation in darker skin tones if parameters are not carefully adjusted.

Pros and Cons: Vivace

Pros

• Minimal downtime — most patients resume social activity within 24–48 hours, making it easy to schedule and rebook.
• More comfortable experience — manageable with topical anesthetic alone for most patients.
• Built-in LED therapy adds a skin-quality benefit to every session without additional equipment or time.
• Gold-coated needles are designed to be gentler on skin, reducing the risk of post-treatment irritation.
• Lower per-session price point makes it accessible for patients earlier in their aesthetic journey.
• Better suited for darker skin tones than aggressive RF treatments due to lower energy and shallower depth.

Cons

• Shallower depth means it cannot address structural laxity or subdermal fat — patients with significant skin sagging will not see adequate correction.
• More sessions required (typically 3–6) to achieve results comparable to 1–2 Morpheus8 sessions, which changes the patient commitment and total cost calculus.
• Less brand recognition than Morpheus8 — requires more marketing and patient education investment from the practice.
• Not appropriate for patients seeking significant lifting or jowl reduction — setting those expectations requires patient screening.

Who Wins for Which Patient

Morpheus8 Is the Better Choice When

• The patient has visible skin laxity — jowling, neck looseness, mid-face sagging — that requires deep structural intervention.
• The patient wants maximum results with fewest sessions and can manage 3–7 days of social downtime.
• Subdermal fat remodeling in addition to skin tightening is a goal (jawline definition, cheek slimming).
• The patient has a higher aesthetic budget and expects a premium-tier treatment experience.

Vivace Is the Better Choice When

• The patient wants skin texture improvement, fine line reduction, and subtle tightening without significant downtime.
• The patient’s schedule does not permit a week of visible recovery — active professionals, parents, or patients with public-facing roles.
• Early preventive treatment in a younger patient who is not yet a candidate for aggressive resurfacing.
• The patient has darker skin and carries higher risk of hyperpigmentation from deep, high-energy treatments.
• The practice wants a high-rebooking, membership-compatible treatment — Vivace’s lower per-session cost and minimal downtime make it ideal for monthly or quarterly maintenance programs.

Common Mistakes When Choosing RF Microneedling

• Offering Morpheus8 to patients who want zero downtime: A patient who asks specifically about minimal recovery is the wrong match for Morpheus8. Mismatching patient expectations to treatment downtime is one of the most consistent sources of negative reviews in aesthetic medicine.
• Using Vivace when structural laxity requires Morpheus8-level depth: Superficial treatments on significantly lax skin can improve texture while the underlying sagging remains unchanged — an outcome that disappoints patients who were hoping for visible lifting.
• Under-numbing patients for Morpheus8: The comfort experience directly affects reviews and rebooking. Providers who are conservative with topical anesthetic on deep-pass Morpheus8 treatments are generating patient discomfort that is entirely preventable.
• Ignoring darker skin tone risk adjustment: Both devices require parameter adjustment for Fitzpatrick types IV–VI. Failing to adjust increases hyperpigmentation risk significantly.
• Not photographing before treatment: RF microneedling results are gradual and cumulative. Without standardized before-and-after documentation, patients and providers cannot objectively assess the improvement after a treatment series.

Protocol Depth Settings and Why They Matter

One of the most consequential operator decisions with any RF microneedling device is the depth setting, and this is where inexperienced providers most commonly underdeliver on Morpheus8 in particular. Because the Morpheus8 Prime tip can reach 8 mm, some providers default to shallower depths — 2–4 mm — to minimize patient discomfort and downtime. At those depths, Morpheus8 is performing similarly to a standard RF microneedling device. The clinical differentiation only emerges at 6–8 mm where the device is reaching the SMAS and subdermal fat.

Appropriate depth selection requires provider training, proper patient numbing, and a thorough pre-treatment consultation to confirm the patient has realistic expectations about the recovery that comes with deeper passes. Patients who are quoted the results of a deep Morpheus8 protocol but receive a conservative shallow treatment are being undersold — and the provider is leaving the device’s primary advantage unused.

For Vivace, depth selection is less nuanced given the 3.5 mm maximum, but energy levels still matter significantly. Under-energizing to minimize any patient sensation during treatment produces subtherapeutic results. The goal is therapeutic discomfort — the patient should feel warmth and mild pressure, not nothing at all.

Building Membership Revenue Around RF Microneedling

Vivace, more than Morpheus8, is naturally suited to a membership or subscription model because of its lower downtime and lower per-session pricing. A quarterly Vivace maintenance program — similar in concept to a quarterly BBL Hero protocol — creates predictable recurring revenue, high retention, and a built-in reason for the patient to be in your practice four times per year where cross-sells are possible.

Morpheus8 fits a different model — annual or bi-annual correction treatments for patients who accept the downtime and invest in fewer, more impactful sessions. Both models are profitable. The membership-compatible treatments tend to generate stronger patient retention numbers because the patient has a consistent relationship with your practice rather than coming in sporadically when they notice aging.

Structuring your RF microneedling offerings to explicitly serve both these patient types — frequent-maintenance patients and periodic-correction patients — gives your treatment menu a coherent logic that makes it easier to consult and convert at initial appointments.

Device Investment and Revenue Modeling for Medspa Owners

Morpheus8 commands a premium price per session and generates high revenue per hour when booked efficiently. Vivace generates lower revenue per session but drives higher rebooking rates and membership compatibility — which can produce equal or greater total revenue per patient per year through frequency.

Run the revenue-per-hour and annual-patient-value models for both treatments through our medspa revenue calculator before making a device investment decision. The right answer depends on your patient demographics, competitive landscape, and staff capacity. For marketing these treatments effectively — including how to position each device for your ideal patient profile — the medspa marketing hub has positioning frameworks specifically for RF microneedling.

If you want to talk through the device investment decision with specific numbers from your practice, book a free strategy call and I’ll give you an honest assessment.